{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:03:58Z","timestamp":1790687038834,"version":"4.1.0"},"reference-count":217,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FEBS Journal"],"abstract":"<jats:p>\n                    Converging findings point to brain\u2010 and body\u2010wide energetic dysregulation in psychotic disorders, implicating metabolic abnormalities across different levels of investigation, including genetic, cellular, postmortem, and\n                    <jats:italic>in vivo<\/jats:italic>\n                    neuroimaging studies. The present review synthesizes this literature documenting aberrant energy production and use, specifically related to mitochondrial and redox dysregulation, in psychotic disorders. Mitochondrial DNA, copy number variants, polygenic risk, and candidate genes involved in metabolic pathways converge on glycolytic, mitochondrial, redox, and oxidative stress mechanisms. Consistent with these findings, cell studies, primarily from\n                    <jats:italic>ex vivo<\/jats:italic>\n                    brain tissue samples and induced pluripotent stem cells (iPSC), show misdistribution and structural fragmentation of mitochondrial networks and dysregulation in the expression of proteins involved in several metabolic processes. Inherent dysregulations, at the genetic and cellular level, may affect both neuronal and glial health, as observed at the tissue level. Neuroimaging studies demonstrate metabolic dysregulations\n                    <jats:italic>in vivo<\/jats:italic>\n                    , including central insulin resistance and redox and bioenergetic aberrations that are associated with cognitive impairment and altered brain networks. We also consider the effects of antipsychotic medications on energy metabolism. Finally, we propose a framework for future work and treatment approaches to target energetic dysregulations, including existing metabolic treatments. The metabolic mechanisms that interact to produce and perpetuate aberrant neuronal health and functioning in psychotic disorders are complex. Nevertheless, the findings highlight pathways that might be targeted for the development of novel treatments, providing an opportunity to develop more efficacious and better\u2010tolerated interventions.\n                  <\/jats:p>","DOI":"10.1111\/febs.70719","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:43:52Z","timestamp":1790685832000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Energetic dysregulations in psychotic disorders: Targets for new therapeutics"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9844-6245","authenticated-orcid":false,"given":"Jacey","family":"Anderson","sequence":"first","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai\u2010Christian","family":"Sonntag","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"},{"name":"Program for Neuropsychiatric Research McLean Hospital, Harvard Medical School  Belmont MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao Do Vy","family":"Le","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Shannon","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Du","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"McPhie","sequence":"additional","affiliation":[{"name":"Program for Neuropsychiatric Research McLean Hospital, Harvard Medical School  Belmont MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"Ongur","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-6285","authenticated-orcid":false,"given":"Bruce","family":"Cohen","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"},{"name":"Program for Neuropsychiatric Research McLean Hospital, Harvard Medical School  Belmont MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7712-2319","authenticated-orcid":false,"given":"Virginie\u2010Anne","family":"Chouinard","sequence":"additional","affiliation":[{"name":"Psychotic Disorders Division McLean Hospital  Belmont MA USA"},{"name":"Department of Psychiatry Harvard Medical School  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s44220-025-00422-6","article-title":"Brain and body energy metabolism and potential for treatment of psychiatric disorders","volume":"3","author":"Andreazza AC","year":"2025","journal-title":"Nature Mental Health"},{"key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.psychres.2016.01.024","article-title":"Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders","volume":"237","author":"Chouinard VA","year":"2016","journal-title":"Psychiatry Res"},{"key":"e_1_2_12_4_1","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15392","article-title":"Baseline cardiovascular risk factors in patients with severe mental illness (SMI) and second generation antipsychotic use from the fixed dose intervention trial of New England enhancing survival in SMI (FITNESS)","volume":"86","author":"Chouinard VA","year":"2025","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","article-title":"Schizophrenia: a disorder of broken brain bioenergetics","volume":"27","author":"Henkel ND","year":"2022","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11920-023-01457-1","article-title":"Magnetic resonance spectroscopy studies of brain energy metabolism in schizophrenia: progression from prodrome to chronic psychosis","volume":"25","author":"Stein A","year":"2023","journal-title":"Curr Psychiatry Rep"},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic Risk in Patients with First\u2010Episode Schizophrenia Spectrum Disorders: Baseline Results from the RAISE\u2010ETP Study","volume":"71","author":"Correll CU","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41380-018-0045-1","article-title":"Impaired insulin signaling in unaffected siblings and patients with first\u2010episode psychosis","volume":"24","author":"Chouinard VA","year":"2019","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.schres.2017.02.024","article-title":"Brain bioenergetics and redox state measured by (31)P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders","volume":"187","author":"Chouinard VA","year":"2017","journal-title":"Schizophr Res"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first\u2010episode schizophrenia: a systematic review and meta\u2010analysis","volume":"74","author":"Pillinger T","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.05.032","article-title":"Brain insulin action: implications for the treatment of schizophrenia","volume":"168","author":"Agarwal SM","year":"2020","journal-title":"Neuropharmacology"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta\u2010analysis","volume":"7","author":"Pillinger T","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113101","article-title":"Roles of inflammation in intrinsic pathophysiology and antipsychotic drug\u2010induced metabolic disturbances of schizophrenia","volume":"402","author":"Prestwood TR","year":"2021","journal-title":"Behav Brain Res"},{"key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamapsychiatry.2025.2240","article-title":"Antipsychotic drugs and dysregulated glucose homeostasis: a systematic review and meta\u2010analysis","volume":"82","author":"Smith ECC","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1169787","article-title":"Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: a pilot study","volume":"14","author":"Lee J","year":"2023","journal-title":"Front Psychiatry"},{"key":"e_1_2_12_16_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijdevneu.2010.08.007","article-title":"Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia","volume":"14","author":"Clay HB","year":"2011","journal-title":"Int J Dev Neurosci"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/ars.2019.7805","article-title":"Leukocyte proteomic profiling in first\u2010episode schizophrenia patients: does oxidative stress play central roles in the pathophysiology network of schizophrenia?","volume":"31","author":"Jiang J","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2020.03.070","article-title":"Increased blood lactate levels during exercise and mitochondrial DNA alterations converge on mitochondrial dysfunction in schizophrenia","volume":"220","author":"Valiente\u2010Palleja A","year":"2020","journal-title":"Schizophr Res"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107022118","article-title":"Brain power","volume":"118","author":"Balasubramanian V","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.1997.77.3.731","article-title":"Cellular energy utilization and molecular origin of standard metabolic rate in mammals","volume":"77","author":"Rolfe DF","year":"1997","journal-title":"Physiol Rev"},{"key":"e_1_2_12_21_1","first-page":"103","article-title":"Blood flow and metabolism of the human brain in health and disease","volume":"18","author":"Kety SS","year":"1950","journal-title":"Trans Stud Coll Physicians Phila"},{"key":"e_1_2_12_22_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2017.10.014","article-title":"Defects in bioenergetic coupling in schizophrenia","volume":"83","author":"Sullivan CR","year":"2018","journal-title":"Biol Psychiatry"},{"key":"e_1_2_12_23_1","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1007\/s11033-020-05590-5","article-title":"The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it?","volume":"47","author":"Morris G","year":"2020","journal-title":"Mol Biol Rep"},{"key":"e_1_2_12_24_1","first-page":"1161","article-title":"The transmission of schizophrenia under a multifactorial threshold model","volume":"35","author":"McGue M","year":"1983","journal-title":"Am J Hum Genet"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41380-020-0654-3","article-title":"Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion","volume":"26","author":"Cleynen I","year":"2021","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_26_1","first-page":"201","article-title":"Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia","volume":"1","author":"Hjelm BE","year":"2015","journal-title":"Mol Neuropsychiatry"},{"key":"e_1_2_12_27_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran S","year":"2004","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_28_1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-023-02005-2","article-title":"The molecular pathology of schizophrenia: an overview of existing knowledge and new directions for future research","volume":"28","author":"Nakamura T","year":"2023","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_29_1","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1089\/ars.2010.3508","article-title":"Genetic association studies of antioxidant pathway genes and schizophrenia","volume":"15","author":"Chowdari KV","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"e_1_2_12_30_1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.biopsych.2018.02.1175","article-title":"A comprehensive analysis of nuclear\u2010encoded mitochondrial genes in schizophrenia","volume":"83","author":"Gon\u00e7alves VF","year":"2018","journal-title":"Biol Psychiatry"},{"key":"e_1_2_12_31_1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh0558","article-title":"Cross\u2010species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia\u2010associated 3q29 deletion","volume":"9","author":"Purcell RH","year":"2023","journal-title":"Sci Adv"},{"key":"e_1_2_12_32_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41583-026-01031-7","article-title":"Mitochondrial dynamics in neurodevelopment and neurodevelopmental disorders","volume":"27","author":"Sirois CL","year":"2026","journal-title":"Nat Rev Neurosci"},{"key":"e_1_2_12_33_1","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00018-016-2165-6","article-title":"G72 primate\u2010specific gene: a still enigmatic element in psychiatric disorders","volume":"73","author":"Sacchi S","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"e_1_2_12_34_1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.mp.4002052","article-title":"Evidence implicating the candidate schizophrenia\/bipolar disorder susceptibility gene G72 in mitochondrial function","volume":"13","author":"Kvajo M","year":"2008","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_35_1","first-page":"28","article-title":"Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia","volume":"2","author":"Harris LW","year":"2009","journal-title":"BMC Med Genet"},{"key":"e_1_2_12_36_1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/sj.ejhg.5201606","article-title":"New variants in the mitochondrial genomes of schizophrenic patients","volume":"14","author":"Martorell L","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"e_1_2_12_37_1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/978-3-642-16712-6_26","volume-title":"Encyclopedia of Biophysics","author":"Brandt U","year":"2013"},{"key":"e_1_2_12_38_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-9964(03)00011-2","article-title":"A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress","volume":"65","author":"Marchbanks RM","year":"2003","journal-title":"Schizophr Res"},{"key":"e_1_2_12_39_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269130","article-title":"NADPH\u2010oxidase 4 gene over\u2010expression in peripheral blood lymphocytes of the schizophrenia patients","volume":"17","author":"Ershova ES","year":"2022","journal-title":"PLoS One"},{"key":"e_1_2_12_40_1","doi-asserted-by":"crossref","first-page":"23240","DOI":"10.1074\/jbc.M115.672360","article-title":"Mitochondrial citrate transporter\u2010dependent metabolic signature in the 22q11.2 deletion syndrome","volume":"290","author":"Napoli E","year":"2015","journal-title":"J Biol Chem"},{"key":"e_1_2_12_41_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0643-y","article-title":"Mitochondrial deficits in human iPSC\u2010derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia","volume":"9","author":"Li J","year":"2019","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2021.0762","article-title":"Association of Mitochondrial Biogenesis with Variable Penetrance of schizophrenia","volume":"78","author":"Li J","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_43_1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/hmg\/ddt485","article-title":"DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking","volume":"23","author":"Ogawa F","year":"2014","journal-title":"Hum Mol Genet"},{"key":"e_1_2_12_44_1","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1073\/pnas.1004361107","article-title":"Disrupted\u2010in\u2010schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin","volume":"107","author":"Park YU","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_12_45_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011093","article-title":"Direct targets of MEF2C are enriched for genes associated with schizophrenia and cognitive function and are involved in neuron development and mitochondrial function","volume":"20","author":"Ali D","year":"2024","journal-title":"PLoS Genet"},{"key":"e_1_2_12_46_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.20132","article-title":"Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample","volume":"127","author":"Stone WS","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"e_1_2_12_47_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089441","article-title":"Pathway analyses implicate glial cells in schizophrenia","volume":"9","author":"Duncan LE","year":"2014","journal-title":"PLoS One"},{"key":"e_1_2_12_48_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nn.3922","article-title":"Psychiatric genome\u2010wide association study analyses implicate neuronal, immune and histone pathways","volume":"18","author":"O'Dushlaine C","year":"2015","journal-title":"Nat Neurosci"},{"key":"e_1_2_12_49_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/YPG.0b013e32832cef21","article-title":"Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia","volume":"19","author":"Butticaz C","year":"2009","journal-title":"Psychiatr Genet"},{"key":"e_1_2_12_50_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2009.12.017","article-title":"Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese","volume":"119","author":"Ma J","year":"2010","journal-title":"Schizophr Res"},{"key":"e_1_2_12_51_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic M","year":"2006","journal-title":"Am J Hum Genet"},{"key":"e_1_2_12_52_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1196\/annals.1432.022","article-title":"Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine\u2010use disorder or schizophrenia in the Japanese population","volume":"1139","author":"Kishi T","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_2_12_53_1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar PK","year":"2003","journal-title":"Psychiatry Res"},{"key":"e_1_2_12_54_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao JK","year":"2006","journal-title":"Dis Markers"},{"key":"e_1_2_12_55_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00041444-200312000-00003","article-title":"A possible association between an insertion\/deletion polymorphism of the NQO2 gene and schizophrenia","volume":"13","author":"Harada S","year":"2003","journal-title":"Psychiatr Genet"},{"key":"e_1_2_12_56_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.b.30791","article-title":"Methionine sulfoxide reductase: a novel schizophrenia candidate gene","volume":"150","author":"Walss\u2010Bass C","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"e_1_2_12_57_1","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1089\/ars.2010.3459","article-title":"The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics","volume":"15","author":"Martins\u2010de\u2010Souza D","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"e_1_2_12_58_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fnins.2017.00493","article-title":"The energy metabolism dysfunction in psychiatric disorders postmortem brains: focus on proteomic evidence","volume":"11","author":"Zuccoli GS","year":"2017","journal-title":"Front Neurosci"},{"key":"e_1_2_12_59_1","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00406-023-01605-x","article-title":"Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC\u2010based neurodevelopmental model for schizophrenia","volume":"273","author":"Zuccoli GS","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"e_1_2_12_60_1","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211191","article-title":"Dopamine signaling impairs ROS modulation by mitochondrial hexokinase in human neural progenitor cells","volume":"41","author":"Assis\u2010de\u2010Lemos G","year":"2021","journal-title":"Biosci Rep"},{"key":"e_1_2_12_61_1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/schbul\/sbae016","article-title":"Elevations in the mitochondrial matrix protein cyclophilin D correlate with reduced parvalbumin expression in the prefrontal cortex of patients with schizophrenia","volume":"50","author":"O'Brien JT","year":"2024","journal-title":"Schizophr Bull"},{"key":"e_1_2_12_62_1","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00180","article-title":"MK\u2010801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia","volume":"9","author":"Guest PC","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"e_1_2_12_63_1","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.226","article-title":"Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia","volume":"6","author":"Dean B","year":"2016","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_64_1","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/pmic.200500069","article-title":"Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease\u2010associated changes","volume":"6","author":"Beasley CL","year":"2006","journal-title":"Proteomics"},{"key":"e_1_2_12_65_1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jpsychires.2008.11.006","article-title":"Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia","volume":"43","author":"Martins\u2010de\u2010Souza D","year":"2009","journal-title":"J Psychiatr Res"},{"key":"e_1_2_12_66_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-244X-9-17","article-title":"Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation","volume":"9","author":"Martins\u2010de\u2010Souza D","year":"2009","journal-title":"BMC Psychiatry"},{"key":"e_1_2_12_67_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biopsych.2010.06.031","article-title":"The neuroproteomics of schizophrenia","volume":"69","author":"English JA","year":"2011","journal-title":"Biol Psychiatry"},{"key":"e_1_2_12_68_1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.euroneuro.2010.10.007","article-title":"Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients","volume":"21","author":"Bubber P","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_2_12_69_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/revneuro-2019-0057","article-title":"Treatment\u2010resistant schizophrenia: focus on the transsulfuration pathway","volume":"31","author":"Berry T","year":"2020","journal-title":"Rev Neurosci"},{"key":"e_1_2_12_70_1","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.3390\/ijms26094415","article-title":"Mitochondrial oxidative phosphorylation system dysfunction in schizophrenia","volume":"26","author":"Mor\u00e9n C","year":"2025","journal-title":"Int J Mol Sci"},{"key":"e_1_2_12_71_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mito.2020.11.009","article-title":"Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies","volume":"56","author":"Roberts RC","year":"2021","journal-title":"Mitochondrion"},{"key":"e_1_2_12_72_1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.biopsych.2011.01.010","article-title":"Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia","volume":"69","author":"Rosenfeld M","year":"2011","journal-title":"Biol Psychiatry"},{"key":"e_1_2_12_73_1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/mp.2013.67","article-title":"Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle\u2010derived induced pluripotent stem cells of schizophrenia patients","volume":"18","author":"Robicsek O","year":"2013","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_74_1","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1038\/s41380-019-0423-3","article-title":"iPSC\u2010derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function","volume":"25","author":"Ni P","year":"2020","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_75_1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jpsychires.2010.04.014","article-title":"Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia","volume":"44","author":"Martins\u2010de\u2010Souza D","year":"2010","journal-title":"J Psychiatr Res"},{"key":"e_1_2_12_76_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2022.06.028","article-title":"Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models","volume":"273","author":"Sebastian R","year":"2024","journal-title":"Schizophr Res"},{"key":"e_1_2_12_77_1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41398-019-0660-x","article-title":"Synaptic deficits in iPSC\u2010derived cortical interneurons in schizophrenia are mediated by NLGN2 and rescued by N\u2010acetylcysteine","volume":"9","author":"Kathuria A","year":"2019","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_78_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/cells7090140","article-title":"Tracing early neurodevelopment in schizophrenia with induced pluripotent stem cells","volume":"7","author":"Ahmad R","year":"2018","journal-title":"Cells"},{"key":"e_1_2_12_79_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/mp.2014.22","article-title":"Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia","volume":"20","author":"Brennand K","year":"2015","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_80_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/syn.20981","article-title":"Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia","volume":"66","author":"Somerville SM","year":"2012","journal-title":"Synapse"},{"key":"e_1_2_12_81_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2353\/ajpath.2010.081068","article-title":"Abnormalities in mitochondrial structure in cells from patients with bipolar disorder","volume":"177","author":"Cataldo AM","year":"2010","journal-title":"Am J Pathol"},{"key":"e_1_2_12_82_1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s13287-020-01980-5","article-title":"Investigation of de novo mutations in a schizophrenia case\u2010parent trio by induced pluripotent stem cell\u2010based in vitro disease modeling: convergence of schizophrenia\u2010 and autism\u2010related cellular phenotypes","volume":"11","author":"Hathy E","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"e_1_2_12_83_1","article-title":"Identifying and targeting abnormal mitochondrial localization associated with psychosis","author":"Haghighi M","year":"2026","journal-title":"bioRxiv"},{"key":"e_1_2_12_84_1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3727\/096368911X600957","article-title":"Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient","volume":"21","author":"Silveira Paulsen B","year":"2012","journal-title":"Cell Transplant"},{"key":"e_1_2_12_85_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s44192-023-00031-8","article-title":"Disease\u2010specific differences in gene expression, mitochondrial function and mitochondria\u2010endoplasmic reticulum interactions in iPSC\u2010derived cerebral organoids and cortical neurons in schizophrenia and bipolar disorder","volume":"3","author":"Kathuria A","year":"2023","journal-title":"Discov Ment Health"},{"key":"e_1_2_12_86_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamapsychiatry.2020.0196","article-title":"Transcriptomic landscape and functional characterization of induced pluripotent stem cell\u2010derived cerebral organoids in schizophrenia","volume":"77","author":"Kathuria A","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_87_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-020-00733-6","article-title":"Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder","volume":"12","author":"Kathuria A","year":"2020","journal-title":"Genome Med"},{"key":"e_1_2_12_88_1","first-page":"97","article-title":"Perturbational profiling of metabolites in patient fibroblasts implicates \u03b1\u2010aminoadipate as a potential biomarker for bipolar disorder","volume":"2","author":"Huang JH","year":"2016","journal-title":"Mol Neuropsychiatry"},{"key":"e_1_2_12_89_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/acs.jproteome.6b00628","article-title":"Unbiased metabolite profiling of schizophrenia fibroblasts under stressful perturbations reveals dysregulation of plasmalogens and phosphatidylcholines","volume":"16","author":"Huang JH","year":"2017","journal-title":"J Proteome Res"},{"key":"e_1_2_12_90_1","volume-title":"Physiology, Cortisol, in StatPearls","author":"Kaur J","year":"2025"},{"key":"e_1_2_12_91_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2025.100764","article-title":"Metabolic state shapes cortisol reactivity to acute stress: a systematic review and meta\u2010analysis of metabolic and hormonal modulators","volume":"39","author":"K\u00f6rdel M","year":"2025","journal-title":"Neurobiol Stress"},{"key":"e_1_2_12_92_1","article-title":"Neurobiological implications of chronic stress and metabolic dysregulation in inflammatory bowel diseases","volume":"12","author":"Sic A","year":"2024","journal-title":"Diseases"},{"key":"e_1_2_12_93_1","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41593-020-00724-1","article-title":"Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia","volume":"23","author":"Park GH","year":"2020","journal-title":"Nat Neurosci"},{"key":"e_1_2_12_94_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s44184-025-00169-z","article-title":"Repurposing medications to prevent psychosis","volume":"4","author":"Cohen BM","year":"2025","journal-title":"Npj Mental Health Research"},{"key":"e_1_2_12_95_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamapsychiatry.2013.2287","article-title":"In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy","volume":"71","author":"Du F","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_96_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","article-title":"Alterations in brain high\u2010energy phosphate and membrane phospholipid metabolism in first\u2010episode, drug\u2010naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy","volume":"48","author":"Pettegrew JW","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_2_12_97_1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuroimage.2006.12.023","article-title":"Metabolic mapping using 2D 31P\u2010MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia","volume":"35","author":"Smesny S","year":"2007","journal-title":"NeuroImage"},{"key":"e_1_2_12_98_1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41386-018-0041-9","article-title":"Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies","volume":"43","author":"Dogan AE","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_12_99_1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.biopsych.2017.03.025","article-title":"Abnormalities in high\u2010energy phosphate metabolism in first\u2010episode bipolar disorder measured using (31)P\u2010magnetic resonance spectroscopy","volume":"84","author":"Du F","year":"2018","journal-title":"Biol Psychiatry"},{"key":"e_1_2_12_100_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/schbul\/sbw129","article-title":"Redox dysregulation in schizophrenia revealed by in vivo NAD+\/NADH measurement","volume":"43","author":"Kim SY","year":"2017","journal-title":"Schizophr Bull"},{"key":"e_1_2_12_101_1","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/s41380-020-00993-z","article-title":"Bioenergetics and abnormal functional connectivity in psychotic disorders","volume":"26","author":"Song X","year":"2021","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_102_1","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgaa073","article-title":"Abnormal brain bioenergetics in first\u2010episode psychosis","volume":"2","author":"Yuksel C","year":"2021","journal-title":"Schizophr Bull Open"},{"key":"e_1_2_12_103_1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/mp.2015.13","article-title":"Abnormal high\u2010energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder","volume":"20","author":"Yuksel C","year":"2015","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_104_1","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbaf003","article-title":"Cognitive impairment in psychotic disorders is associated with brain reductive stress and impaired energy metabolism as measured by 31P magnetic resonance spectroscopy","volume":"52","author":"Chouinard V\u2010A","year":"2025","journal-title":"Schizophr Bull"},{"key":"e_1_2_12_105_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/mrm.1910380408","article-title":"Increase of creatine kinase activity in the visual cortex of human brain during visual stimulation: a 31P magnetization transfer study","volume":"38","author":"Chen W","year":"1997","journal-title":"Magn Reson Med"},{"key":"e_1_2_12_106_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2020.09.003","article-title":"Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: a focused review and meta\u2010analysis of human postmortem and magnetic resonance spectroscopy studies","volume":"223","author":"Pruett BS","year":"2020","journal-title":"Schizophr Res"},{"key":"e_1_2_12_107_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41537-022-00293-1","article-title":"In vivo 7\u2010tesla MRI investigation of brain iron and its metabolic correlates in chronic schizophrenia","volume":"8","author":"Ravanfar P","year":"2022","journal-title":"Schizophrenia (Heidelb)"},{"key":"e_1_2_12_108_1","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.239","article-title":"Elevated brain lactate in schizophrenia: a 7\u2009T magnetic resonance spectroscopy study","volume":"6","author":"Rowland LM","year":"2016","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_109_1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.656459","article-title":"Metabolite alterations in adults with schizophrenia, first degree relatives, and healthy controls: a multi\u2010region 7\u2009T MRS study","volume":"12","author":"Wijtenburg SA","year":"2021","journal-title":"Front Psychiatry"},{"key":"e_1_2_12_110_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028427","article-title":"Lactate produced by glycogenolysis in astrocytes regulates memory processing","volume":"6","author":"Newman LA","year":"2011","journal-title":"PLoS One"},{"key":"e_1_2_12_111_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpsychires.2020.03.006","article-title":"Magnetic resonance spectroscopy studies in subjects with high risk for psychosis: a meta\u2010analysis and review","volume":"125","author":"Romeo B","year":"2020","journal-title":"J Psychiatr Res"},{"key":"e_1_2_12_112_1","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.84","article-title":"A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder","volume":"2","author":"Brady RO","year":"2012","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_113_1","first-page":"286","article-title":"Intranasal insulin increases brain glutathione and enhances antioxidant capacity in healthy participants but not in those with early psychotic disorders","volume":"10","author":"Chouinard VA","year":"2025","journal-title":"Biol Psychiatry: Cognit Neurosci Neuroimaging"},{"key":"e_1_2_12_114_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/272827a0","article-title":"Insulin receptors are widely distributed in the central nervous system of the rat","volume":"272","author":"Havrankova J","year":"1978","journal-title":"Nature"},{"key":"e_1_2_12_115_1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0301-0082(91)90015-S","article-title":"Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects","volume":"36","author":"Unger JW","year":"1991","journal-title":"Prog Neurobiol"},{"key":"e_1_2_12_116_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2004.02.045","article-title":"Insulin and the insulin receptor in experimental models of learning and memory","volume":"490","author":"Zhao WQ","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"e_1_2_12_117_1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann S","year":"2016","journal-title":"Physiol Rev"},{"key":"e_1_2_12_118_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel AR","year":"2001","journal-title":"Nature"},{"key":"e_1_2_12_119_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi CM","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"e_1_2_12_120_1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.796466","article-title":"Schizophrenia increases variability of the central antioxidant system: a meta\u2010analysis of variance from MRS studies of glutathione","volume":"12","author":"Palaniyappan L","year":"2021","journal-title":"Front Psychiatry"},{"key":"e_1_2_12_121_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbi.2023.09.017","article-title":"Measurement of brain glutathione with magnetic resonance spectroscopy in schizophrenia\u2010Spectrum disorders \u2010 a systematic review and meta\u2010analysis","volume":"115","author":"Murray AJ","year":"2024","journal-title":"Brain Behav Immun"},{"key":"e_1_2_12_122_1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703452","article-title":"Oxidative stress and the pathophysiology and symptom profile of schizophrenia Spectrum disorders","volume":"12","author":"Murray AJ","year":"2021","journal-title":"Front Psychiatry"},{"key":"e_1_2_12_123_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"1H\u2010MRS at 4 tesla in minimally treated early schizophrenia","volume":"15","author":"Bustillo JR","year":"2010","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_124_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/antiox10010075","article-title":"Counteracting effects of glutathione on the glutamate\u2010driven excitation\/inhibition imbalance in first\u2010episode schizophrenia: a 7\u2009T MRS and dynamic causal modeling study","volume":"10","author":"Limongi R","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"e_1_2_12_125_1","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0\u2009T proton MRS in never\u2010treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Th\u00e9berge J","year":"2002","journal-title":"Am J Psychiatry"},{"key":"e_1_2_12_126_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pnpbp.2018.08.006","article-title":"Antioxidant defense in schizophrenia and bipolar disorder: a meta\u2010analysis of MRS studies of anterior cingulate glutathione","volume":"91","author":"Das TK","year":"2019","journal-title":"Prog Neuro\u2010Psychopharmacol Biol Psychiatry"},{"key":"e_1_2_12_127_1","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgab006","article-title":"Glutathione levels and glutathione\u2010glutamate correlation in patients with treatment\u2010resistant schizophrenia","volume":"2","author":"Iwata Y","year":"2021","journal-title":"Schizophr Bull Open"},{"key":"e_1_2_12_128_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2020.06.028","article-title":"A meta\u2010analysis of ultra\u2010high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: implications for studies of psychosis risk","volume":"226","author":"Sydnor VJ","year":"2020","journal-title":"Schizophr Res"},{"key":"e_1_2_12_129_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamapsychiatry.2018.3637","article-title":"Assessing brain metabolism with 7\u2010T proton magnetic resonance spectroscopy in patients with first\u2010episode psychosis","volume":"76","author":"Wang AM","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_130_1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/schbul\/sbac012","article-title":"Central oxidative stress and early vocational outcomes in first episode psychosis: a 7\u2010tesla magnetic resonance spectroscopy study of glutathione","volume":"48","author":"MacKinley M","year":"2022","journal-title":"Schizophr Bull"},{"key":"e_1_2_12_131_1","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/s41380-023-01969-5","article-title":"Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7\u2010tesla MRS study","volume":"28","author":"Wang M","year":"2023","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_132_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.30773\/pi.2024.0150","article-title":"Diminished compensatory energy production following hypoxic stress in the prefrontal and anterior cingulate cortex among individuals with schizophrenia","volume":"22","author":"Baytunca MB","year":"2025","journal-title":"Psychiatry Investig"},{"key":"e_1_2_12_133_1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00210-019-01665-8","article-title":"In vitro effects of antipsychotics on mitochondrial respiration","volume":"392","author":"Cik\u00e1nkov\u00e1 T","year":"2019","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"e_1_2_12_134_1","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1007\/s12035-021-02498-4","article-title":"Effect of novel antipsychotics on energy metabolism \u2010 in vitro study in pig brain mitochondria","volume":"58","author":"\u013dupt\u00e1k M","year":"2021","journal-title":"Mol Neurobiol"},{"key":"e_1_2_12_135_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/BF02980205","article-title":"Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro","volume":"26","author":"Modica\u2010Napolitano JS","year":"2003","journal-title":"Arch Pharm Res"},{"key":"e_1_2_12_136_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13062-023-00375-9","article-title":"The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off\u2010target respiratory chain complex I inhibitors","volume":"18","author":"Hardy RE","year":"2023","journal-title":"Biol Direct"},{"key":"e_1_2_12_137_1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00406-023-01727-2","article-title":"Effects of antipsychotic drugs on energy metabolism","volume":"274","author":"Panizzutti B","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"e_1_2_12_138_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.euroneuro.2018.01.004","article-title":"Second generation antipsychotic\u2010induced mitochondrial alterations: implications for increased risk of metabolic syndrome in patients with schizophrenia","volume":"28","author":"Scaini G","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_2_12_139_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00210-007-0178-2","article-title":"Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain","volume":"376","author":"Streck EL","year":"2007","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"e_1_2_12_140_1","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.euroneuro.2006.06.003","article-title":"Differential metabolic effects of antipsychotic treatments","volume":"16","author":"Haupt DW","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_2_12_141_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.euroneuro.2020.08.009","article-title":"A 3\u2010year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: a pragmatic clinical trial in first episode psychosis patients","volume":"39","author":"V\u00e1zquez\u2010Bourgon J","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_2_12_142_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-017-4763-x","article-title":"Long\u2010term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug\u2010na\u00efve patients with a first\u2010episode of non\u2010affective psychosis","volume":"235","author":"V\u00e1zquez\u2010Bourgon J","year":"2018","journal-title":"Psychopharmacology"},{"key":"e_1_2_12_143_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.02.028","article-title":"Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum","volume":"591","author":"Andreazza AC","year":"2015","journal-title":"Neurosci Lett"},{"key":"e_1_2_12_144_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(98)00925-X","article-title":"Haloperidol\u2010induced changes in glutathione and energy metabolism: effect of nicergoline","volume":"367","author":"Vairetti M","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"e_1_2_12_145_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/ph13120457","article-title":"Antioxidant properties of second\u2010generation antipsychotics: focus on microglia","volume":"13","author":"Caruso G","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"e_1_2_12_146_1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","article-title":"Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses","volume":"2","author":"Henderson DC","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"e_1_2_12_147_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41398-020-01171-z","article-title":"Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors","volume":"11","author":"Aslanoglou D","year":"2021","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_148_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db22-0522","article-title":"Roles of pancreatic islet catecholamine neurotransmitters in glycemic control and in antipsychotic drug\u2010induced Dysglycemia","volume":"72","author":"Freyberg Z","year":"2023","journal-title":"Diabetes"},{"key":"e_1_2_12_149_1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2015.03.122","article-title":"Bioenergetic disruption of human micro\u2010vascular endothelial cells by antipsychotics","volume":"460","author":"Elmorsy E","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_2_12_150_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.psyneuen.2019.01.029","article-title":"Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons","volume":"104","author":"Kowalchuk C","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"e_1_2_12_151_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104400","article-title":"Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons","volume":"109","author":"Kowalchuk C","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"e_1_2_12_152_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tem.2014.07.004","article-title":"Molecular pathophysiology of metabolic effects of antipsychotic medications","volume":"25","author":"Ballon JS","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"e_1_2_12_153_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0925-4927(02)00007-0","article-title":"Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?\u2010a (31)P\u2010MRS study on three different patient groups","volume":"114","author":"Riehemann S","year":"2002","journal-title":"Psychiatry Res"},{"key":"e_1_2_12_154_1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.npp.1300950","article-title":"Neurochemical effects of olanzapine in first\u2010hospitalization manic adolescents: a proton magnetic resonance spectroscopy study","volume":"31","author":"DelBello MP","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_12_155_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hup.2558","article-title":"The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic\u2010naive first\u2010episode schizophrenic patients","volume":"31","author":"Yoshimuta H","year":"2016","journal-title":"Hum Psychopharmacol"},{"key":"e_1_2_12_156_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hup.2274","article-title":"Effects of olanzapine on 31P MRS metabolic markers in schizophrenia","volume":"28","author":"Nenadic I","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"e_1_2_12_157_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40501-024-00339-4","article-title":"The ketogenic diet as a transdiagnostic treatment for neuropsychiatric disorders: mechanisms and clinical outcomes","volume":"12","author":"Anderson J","year":"2024","journal-title":"Curr Treat Options Psychiatry"},{"key":"e_1_2_12_158_1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.951376","article-title":"The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients","volume":"13","author":"Danan A","year":"2022","journal-title":"Front Psychiatry"},{"key":"e_1_2_12_159_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/alz.12206","article-title":"A ketogenic drink improves cognition in mild cognitive impairment: results of a 6\u2010month RCT","volume":"17","author":"Fortier M","year":"2021","journal-title":"Alzheimers Dement"},{"key":"e_1_2_12_160_1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jamapsychiatry.2025.4431","article-title":"A ketogenic diet for treatment\u2010resistant depression: a randomized clinical trial","volume":"83","author":"Gao M","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_161_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamapsychiatry.2025.3261","article-title":"Ketogenic diets and depression and anxiety: a systematic review and meta\u2010analysis","volume":"83","author":"Janssen\u2010Aguilar R","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_162_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2025.10.008","article-title":"Reductive stress and dysregulated energy metabolism in schizophrenia: mechanisms and therapeutic targets","volume":"100","author":"Memetoglu O","year":"2025","journal-title":"Biol Psychiatry"},{"key":"e_1_2_12_163_1","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.568","article-title":"Pilot study of a ketogenic diet in bipolar disorder","volume":"9","author":"Needham N","year":"2023","journal-title":"BJPsych Open"},{"key":"e_1_2_12_164_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40501-024-00322-z","article-title":"The ketogenic diet as a treatment for mood disorders","volume":"11","author":"Ozan E","year":"2024","journal-title":"Curr Treat Options Psychiatry"},{"key":"e_1_2_12_165_1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ijnp\/pyaa036","article-title":"Ketogenic therapy in serious mental illness: emerging evidence","volume":"23","author":"Sarnyai Z","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_12_166_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115866","article-title":"Ketogenic diet intervention on metabolic and psychiatric health in bipolar and schizophrenia: a pilot trial","volume":"335","author":"Sethi S","year":"2024","journal-title":"Psychiatry Res"},{"key":"e_1_2_12_167_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11064-018-2588-6","article-title":"A ketogenic diet improves mitochondrial biogenesis and bioenergetics via the PGC1alpha\u2010SIRT3\u2010UCP2 Axis","volume":"44","author":"Hasan\u2010Olive MM","year":"2019","journal-title":"Neurochem Res"},{"key":"e_1_2_12_168_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnut.2018.00062","article-title":"Nutritional ketosis increases NAD(+)\/NADH ratio in healthy human brain: an in vivo study by (31)P\u2010MRS","volume":"5","author":"Xin L","year":"2018","journal-title":"Front Nutr"},{"key":"e_1_2_12_169_1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41380-024-02431-w","article-title":"The metabolic overdrive hypothesis: hyperglycolysis and glutaminolysis in bipolar mania","volume":"29","author":"Campbell IH","year":"2024","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_170_1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41398-025-03544-8","article-title":"A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder","volume":"15","author":"Decker DD","year":"2025","journal-title":"Transl Psychiatry"},{"key":"e_1_2_12_171_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1444483","article-title":"The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol","volume":"11","author":"Longhitano C","year":"2024","journal-title":"Front Nutr"},{"key":"e_1_2_12_172_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/dom.12795","article-title":"Effect of GLP\u20101 receptor agonist treatment on body weight in obese antipsychotic\u2010treated patients with schizophrenia: a randomized, placebo\u2010controlled trial","volume":"19","author":"Ish\u00f8y PL","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"e_1_2_12_173_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jamapsychiatry.2017.1220","article-title":"Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine\u2010 or olanzapine\u2010treated patients with schizophrenia Spectrum disorder: a randomized clinical trial","volume":"74","author":"Larsen JR","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_174_1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/dom.13167","article-title":"Treatment of clozapine\u2010associated obesity and diabetes with exenatide in adults with schizophrenia: a randomized controlled trial (CODEX)","volume":"20","author":"Siskind DJ","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"e_1_2_12_175_1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/dom.14334","article-title":"The use of liraglutide 3.0\u2009mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: results of a pilot randomized, double\u2010blind, placebo\u2010controlled trial","volume":"23","author":"Whicher CA","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"e_1_2_12_176_1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1127634","article-title":"Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism","volume":"14","author":"Medak KD","year":"2023","journal-title":"Front Pharmacol"},{"key":"e_1_2_12_177_1","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231165169","article-title":"Semaglutide for the treatment of antipsychotic\u2010associated weight gain in patients not responding to metformin \u2010 a case series","volume":"13","author":"Prasad F","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"key":"e_1_2_12_178_1","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1152\/ajpendo.00409.2011","article-title":"Acute activation of central GLP\u20101 receptors enhances hepatic insulin action and insulin secretion in high\u2010fat\u2010fed, insulin resistant mice","volume":"302","author":"Burmeister MA","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"e_1_2_12_179_1","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI25764","article-title":"Brain glucagon\u2010like peptide\u20101 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage","volume":"115","author":"Knauf C","year":"2005","journal-title":"J Clin Invest"},{"key":"e_1_2_12_180_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","article-title":"Revisiting the complexity of GLP\u20101 action from sites of synthesis to receptor activation","volume":"42","author":"McLean BA","year":"2021","journal-title":"Endocr Rev"},{"key":"e_1_2_12_181_1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/dom.70400","article-title":"Beyond diabetes and obesity: GLP\u20101 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation","volume":"28","author":"Spezani R","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"e_1_2_12_182_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.11.021","article-title":"GLP\u20101 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP\u20101 on emotionality","volume":"65","author":"Anderberg RH","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"e_1_2_12_183_1","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.614884","article-title":"Can GLP\u20101 Be a target for reward system related disorders? A qualitative synthesis and systematic review analysis of studies on palatable food, drugs of abuse, and alcohol","volume":"14","author":"Eren\u2010Yazicioglu CY","year":"2020","journal-title":"Front Behav Neurosci"},{"key":"e_1_2_12_184_1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jamapsychiatry.2025.2332","article-title":"Semaglutide treatment of antipsychotic\u2010treated patients with schizophrenia, prediabetes, and obesity: the HISTORI randomized clinical trial","volume":"82","author":"Ganeshalingam AA","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_12_185_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111567","article-title":"Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing","volume":"199","author":"Reiten OK","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"e_1_2_12_186_1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD(+) in Brain Aging and Neurodegenerative Disorders","volume":"30","author":"Lautrup S","year":"2019","journal-title":"Cell Metab"},{"key":"e_1_2_12_187_1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","article-title":"Regulation of and challenges in targeting NAD+ metabolism","volume":"25","author":"Migaud ME","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"e_1_2_12_188_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/schbul\/sbx093","article-title":"N\u2010acetylcysteine in a double\u2010blind randomized placebo\u2010controlled trial: toward biomarker\u2010guided treatment in early psychosis","volume":"44","author":"Conus P","year":"2018","journal-title":"Schizophr Bull"},{"key":"e_1_2_12_189_1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s13063-019-3786-5","article-title":"ENACT: a protocol for a randomised placebo\u2010controlled trial investigating the efficacy and mechanisms of action of adjunctive N\u2010acetylcysteine for first\u2010episode psychosis","volume":"20","author":"Cotton SM","year":"2019","journal-title":"Trials"},{"key":"e_1_2_12_190_1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/bph.15456","article-title":"N\u2010acetylcysteine as a new prominent approach for treating psychiatric disorders","volume":"178","author":"Smaga I","year":"2021","journal-title":"Br J Pharmacol"},{"key":"e_1_2_12_191_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","article-title":"Meta\u2010analysis of randomised controlled trials with N\u2010acetylcysteine in the treatment of schizophrenia","volume":"54","author":"Yolland CO","year":"2020","journal-title":"Aust N Z J Psychiatry"},{"key":"e_1_2_12_192_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41587-019-0377-7","article-title":"An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD(+) imbalance","volume":"38","author":"Patgiri A","year":"2020","journal-title":"Nat Biotechnol"},{"key":"e_1_2_12_193_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.aad4017","article-title":"Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio","volume":"352","author":"Titov DV","year":"2016","journal-title":"Science"},{"key":"e_1_2_12_194_1","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke JD","year":"2024","journal-title":"N Engl J Med"},{"key":"e_1_2_12_195_1","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.18632\/aging.103954","article-title":"Rapamycin maintains NAD(+)\/NADH redox homeostasis in muscle cells","volume":"12","author":"Zhang Z","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"e_1_2_12_196_1","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa007","article-title":"GDF15: a hormone conveying somatic distress to the brain","volume":"41","author":"Lockhart SM","year":"2020","journal-title":"Endocr Rev"},{"key":"e_1_2_12_197_1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 provides an endocrine signal of nutritional stress in mice and humans","volume":"29","author":"Patel S","year":"2019","journal-title":"Cell Metab"},{"key":"e_1_2_12_198_1","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1038\/s41598-017-07503-2","article-title":"Plasma GDF15 level is elevated in psychosis and inversely correlated with severity","volume":"7","author":"Kumar P","year":"2017","journal-title":"Sci Rep"},{"key":"e_1_2_12_199_1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s12325-024-02813-0","article-title":"An update on Stiripentol mechanisms of action: a narrative review","volume":"41","author":"Bacq A","year":"2024","journal-title":"Adv Ther"},{"key":"e_1_2_12_200_1","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3390\/pharmaceutics14122624","article-title":"Gossypol and its natural derivatives: multitargeted phytochemicals as potential drug candidates for oncologic diseases","volume":"14","author":"Pal D","year":"2022","journal-title":"Pharmaceutics"},{"key":"e_1_2_12_201_1","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3390\/biom11121827","article-title":"Hyperbaric oxygen treatment: effects on mitochondrial function and oxidative stress","volume":"11","author":"Schottlender N","year":"2021","journal-title":"Biomolecules"},{"key":"e_1_2_12_202_1","doi-asserted-by":"crossref","first-page":"E4241","DOI":"10.1073\/pnas.1621511114","article-title":"Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome","volume":"114","author":"Ferrari M","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_12_203_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymgme.2021.03.005","article-title":"Hypoxia ameliorates brain hyperoxia and NAD(+) deficiency in a murine model of Leigh syndrome","volume":"133","author":"Grange RMH","year":"2021","journal-title":"Mol Genet Metab"},{"key":"e_1_2_12_204_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tins.2021.11.002","article-title":"The iPSC perspective on schizophrenia","volume":"45","author":"R\u00e4s\u00e4nen N","year":"2022","journal-title":"Trends Neurosci"},{"key":"e_1_2_12_205_1","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300409","article-title":"Progress in the research of lactate metabolism disruption and astrocyte\u2010neuron lactate shuttle impairment in schizophrenia: a comprehensive review","volume":"8","author":"Zhang Y","year":"2024","journal-title":"Adv Biol (Weinh)"},{"key":"e_1_2_12_206_1","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1007\/s12035-023-03502-9","article-title":"Dissecting the relationship between neuropsychiatric and neurodegenerative disorders","volume":"60","author":"Gupta R","year":"2023","journal-title":"Mol Neurobiol"},{"key":"e_1_2_12_207_1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits","volume":"47","author":"Bulik\u2010Sullivan B","year":"2015","journal-title":"Nat Genet"},{"key":"e_1_2_12_208_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002117","article-title":"Hypoxia extends lifespan and neurological function in a mouse model of aging","volume":"21","author":"Rogers RS","year":"2023","journal-title":"PLoS Biol"},{"key":"e_1_2_12_209_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41380-017-0010-4","article-title":"Psychiatric genetics and the structure of psychopathology","volume":"24","author":"Smoller JW","year":"2019","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_210_1","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41467-022-31873-5","article-title":"Shared mechanisms across the major psychiatric and neurodegenerative diseases","volume":"13","author":"Wingo TS","year":"2022","journal-title":"Nat Commun"},{"key":"e_1_2_12_211_1","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3390\/ijms27114932","article-title":"The role of the ketogenic diet in modulating biochemical pathophysiology in psychiatric and neurodegenerative disorders","volume":"27","author":"Chang YB","year":"2026","journal-title":"Int J Mol Sci"},{"key":"e_1_2_12_212_1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.bcp.2004.02.015","article-title":"Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine\u2010related neuropsychiatric disorders","volume":"67","author":"Ben\u2010Shachar D","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"e_1_2_12_213_1","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/s41380-026-03460-3","article-title":"Aerobic glycolysis in schizophrenia: developmental rescue or energetic breakdown?","volume":"31","author":"Memetoglu O","year":"2026","journal-title":"Mol Psychiatry"},{"key":"e_1_2_12_214_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103999","article-title":"Alterations in lipid, redox, and energy metabolism in recent onset psychosis: a metabolomics study in non\u2010smoking individuals and matched controls","volume":"89","author":"Dielemans DAM","year":"2026","journal-title":"Redox Biol"},{"key":"e_1_2_12_215_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116220","article-title":"Schizophrenia, a disease of impaired dynamic metabolic flexibility: a new mechanistic framework","volume":"342","author":"Sarnyai Z","year":"2024","journal-title":"Psychiatry Res"},{"key":"e_1_2_12_216_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ijnp\/pyx094","article-title":"Glutathione, the major redox regulator, in the prefrontal cortex of individuals at clinical high risk for psychosis","volume":"21","author":"Da Silva T","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"e_1_2_12_217_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24355-6","article-title":"Mitochondrial function in individuals at clinical high risk for psychosis","volume":"8","author":"Da Silva T","year":"2018","journal-title":"Sci Rep"},{"key":"e_1_2_12_218_1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/brainsci11070941","article-title":"Glutathione as a molecular marker of functional impairment in patients with At\u2010risk mental state: 7\u2010tesla (1)H\u2010MRS study","volume":"11","author":"Jeon P","year":"2021","journal-title":"Brain Sci"}],"container-title":["The FEBS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/febs.70719","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/febs.70719","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/febs.70719","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:18Z","timestamp":1790685858000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/febs.70719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":217,"alternative-id":["10.1111\/febs.70719"],"URL":"https:\/\/doi.org\/10.1111\/febs.70719","archive":["Portico"],"relation":{},"ISSN":["1742-464X","1742-4658"],"issn-type":[{"value":"1742-464X","type":"print"},{"value":"1742-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"2026-04-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"febs.70719"}}